N. Barreto

Isolated Components From Spider Venom Targeting Human Glioblastoma Cells and Its Potential Combined Therapy With Rapamycin

C. Rapôso, Marcus Caballero, N. Barreto, 2022, Frontiers in Molecular Biosciences.

Spider venom components decrease glioblastoma cell migration and invasion through RhoA-ROCK and Na+/K+-ATPase β2: potential molecular entities to treat invasive brain cancer

C. Rapôso, Marcus Caballero, N. Barreto, 2020, Cancer Cell International.

Health inequities in the diagnosis and outcome of sepsis in Argentina: a prospective cohort study

A. Dubin, E. Estenssoro, F. Pálizas, 2019, Critical Care.

Isolated Peptide from Spider Venom Modulates Dendritic Cells In Vitro: A Possible Application in Oncoimmunotherapy for Glioblastoma

C. Rapôso, N. Barreto, A. Bonfanti, 2023, Cells.

Spider venom administration impairs glioblastoma growth and modulates immune response in a non-clinical model

C. Rapôso, R. Thome, Marcus Caballero, 2020, Scientific Reports.

Components from spider venom activate macrophages against glioblastoma cells: new potential adjuvants for anticancer immunotherapy.

C. Rapôso, Elahe Gharagouzloo, R. Thome, 2021, Journal of biochemistry.

Characteristics of resuscitation, and association between use of dynamic tests of fluid responsiveness and outcomes in septic patients: results of a multicenter prospective cohort study in Argentina

A. Dubin, E. Estenssoro, F. Pálizas, 2020, Annals of Intensive Care.

Components from spider venom activate macrophages against glioblastoma cells: new potential adjuvants for anticancer immunotherapy.

Elahe Gharagouzloo, R. Thome, N. Barreto, 2020, Journal of biochemistry.